Carregant...
Curcumin Inhibits Hepatocellular Carcinoma via Regulating miR-21/TIMP3 Axis
BACKGROUND/AIM: Curcumin exhibits anticancer effects against various types of cancer including hepatocellular carcinoma (HCC). miR-21 has been reported to be involved in the malignant biological properties of HCC. However, whether miR-21 plays a role in curcumin-mediated treatment of HCC is unknown....
Guardat en:
| Publicat a: | Evid Based Complement Alternat Med |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7382716/ https://ncbi.nlm.nih.gov/pubmed/32724322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2892917 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|